ClearView Wealth (CVW) Subordinated Notes

Original IAM Trade Idea: ClearView Wealth Subordinated Notes: 

Last week, ClearView shareholders overwhelmingly approved the acquisition by Zurich Financial Services Australia Limited, with 99.34% of votes cast in favour of the scheme of arrangement. The Supreme Court of New South Wales approved the scheme of arrangement, paving the way for the transaction to be completed in August 2026.

This outcome aligns with the investment thesis IAM first published in April 2025, where we identified ClearView’s subordinated notes as an attractive credit opportunity supported by the potential for consolidation within the life insurance sector.

Investors who purchased the notes following our recommendation can now exit at a significant premium generating an annualised internal rate of return (IRR) of approximately 10% over the holding period.

With the takeover premium largely captured, we believe it is an appropriate time to crystallise gains and redeploy capital into opportunities where we currently see superior risk-adjusted value. Selling at current levels locks in the circa 10% annualised return, allowing us to rotate proceeds into opportunities where we currently see better value.

For reinvestment, we recommend the following two opportunities. The Barclays AT1 carries the same Fitch rating while offering a higher running yield and yield to call. The TEEG Senior Secured notes are a core position in IAM’s Managed Discretionary Account (MDA) offering short-dated, senior secured floating-rate exposure supported by an institutional lending structure and strong covenant headroom. Please contact IAM for additional information and pricing.

Original IAM Trade Idea (March 2025)

ClearView Wealth Ltd (ASX: CVW) presented an attractive opportunity underpinned by its strategic transformation into a pure-play life insurer and the potential for an acquisition within the following one to two years.

Investment Thesis

The global life insurance industry continues to consolidate, with a small number of major international insurers actively seeking growth through acquisitions. Recent transactions, including Dai-ichi Life Holdings’ acquisition of Partners Life in New Zealand and TAL’s strategic investment in Challenger, demonstrated the continued appetite for consolidation across the sector.

Why ClearView?

ClearView had strategically repositioned itself by divesting its Wealth Management and Financial Advice businesses to become a pure-play life insurer, significantly enhancing its attractiveness as a potential acquisition target.

The subordinated notes were rated BB+ by Fitch, two notches below the issuer rating of BBB. A successful acquisition by a larger global insurer had the potential to improve the issuer’s overall credit profile and drive tighter trading margins for the subordinated debt.
About the Issuer

Last week, shareholders of ClearView Wealth approved the acquisition of ClearView’s subordinated notes issuer by Zurich Financial Services Australia…ClearView is an APRA-regulated life insurer originally established as NRMA Life in 1976 before relaunching as ClearView in 2010. The company is ASX-listed and carries a BBB issuer rating from Fitch.

At the time of publication, we believed the subordinated notes offered investors an attractive combination of compelling running income together with the potential for capital appreciation should a takeover event occur.

Today:

That investment thesis has now played out broadly as anticipated. With the investment thesis realised and the takeover premium reflected in pricing, IAM recommends crystallising gains and rotating into Barclays AT1 or TEEG Senior Secured Notes. Please contact IAM for additional information and pricing.